Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.60

-$0.02 (-3.54%)

Nov 2, 2026, 11:02 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	300K	243K	367K	n/a	n/a	n/a	n/a	n/a
Gross Profit	-300K	-243K	-367K	n/a	n/a	n/a	n/a	n/a
Operating Income	-9.39M	-11.17M	-13.55M	-11.86M	-45.39M	-24.59M	-29.49M	-30.62M
Interest Income	747K	789K	974K	1.17M	1.21M	1.27M	1.8M	2.62M
Pretax Income	-8.6M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-27.6M	-27.94M
Net Income	-8.6M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-27.6M	-27.94M
Selling & General & Admin	5.79M	6.38M	9.33M	7.91M	40.28M	10.92M	8.96M	12.95M
Research & Development	3.3M	4.54M	3.85M	3.96M	5.12M	13.67M	20.53M	17.68M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.09M	10.93M	13.19M	11.86M	45.39M	24.59M	29.49M	30.62M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.39M	11.17M	13.55M	11.86M	45.39M	24.59M	29.49M	30.62M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	48.1M	47.98M
Shares Outstanding (Diluted)	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	4.81B	47.98M
EPS (Basic)	-0.18	-0.21	-0.26	-0.22	-0.92	-0.48	-0.57	-0.58
EPS (Diluted)	-0.18	-0.21	-0.26	-0.22	-0.92	-0.48	-0.57	-0.58
EBITDA	-9.09M	-10.09M	-12.17M	-10.68M	-44.01M	-23.18M	-30.06M	-27.68M
EBIT	-9.39M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-30.32M	-27.94M
Depreciation & Amortization	300K	243K	367K	131K	218K	220K	260K	259K